Fundraising FoxSingular Bio
acquired by InvitaeSan Francisco, US · Delaware corporation · 1 known investors
Find your way into Singular Bio
Sign up to see every warm intro you have to Singular Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Singular Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genetic screening platform for early pregnancy, acquired by Invitae.
Founders & leadership
JH
Jones HywelNamed on SEC filing
Board
EC
Eli CasdinBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 1 round · 2019
▶$6.6MraisedFeb 2019 · 8 investors · Other Health CareRule 506(b)
▶$6.6MraisedFeb 2019 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eli CasdinDirector
- Jones HywelExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $6.6M
- Minimum investment
- $1
- Sales commissions
- $400K
- Placement agents
- Raymond James & Associates, Inc.
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Singular Bio do?
- Genetic screening platform for early pregnancy, acquired by Invitae.
- Who are Singular Bio's investors?
- Singular Bio's investors include Civilization Ventures Management, Llc.
- How much funding has Singular Bio raised?
- Singular Bio has disclosed $6.6M raised across 1 round.
- Who acquired Singular Bio?
- Singular Bio was acquired by Invitae.
- Where is Singular Bio headquartered?
- Singular Bio is headquartered in San Francisco, US.